HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew Plummer Selected Research

Cobicistat

6/2015Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.
3/2014A randomized, double-blind comparison of single-tablet regimen elvitegravir/cobicistat/emtricitabine/tenofovir DF versus single-tablet regimen efavirenz/emtricitabine/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results.
5/2013A randomized double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: analysis of week 96 results.
4/2013A randomized, double-blind comparison of coformulated elvitegravir/cobicistat/emtricitabine/tenofovir DF vs ritonavir-boosted atazanavir plus coformulated emtricitabine and tenofovir DF for initial treatment of HIV-1 infection: analysis of week 96 results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrew Plummer Research Topics

Disease

6Infections
04/2016 - 04/2013
2COVID-19
01/2024 - 12/2023
1Human Influenza (Influenza)
01/2024
1Viremia
01/2018
1Renal Insufficiency (Renal Failure)
06/2015
1Proteinuria
06/2015

Drug/Important Bio-Agent (IBA)

6Tenofovir (Viread)FDA Link
04/2016 - 04/2013
5Emtricitabine (Emtriva)FDA Link
04/2016 - 04/2013
4CobicistatIBA
06/2015 - 04/2013
4elvitegravirIBA
06/2015 - 04/2013
3tenofovir alafenamideIBA
04/2016 - 06/2015
2Antiviral Agents (Antivirals)IBA
01/2024 - 12/2023
2efavirenz (Sustiva)FDA Link
03/2014 - 05/2013
1Protease Inhibitors (Protease Inhibitor)IBA
02/2024
1PBI-0451IBA
02/2024
1Peptide Hydrolases (Proteases)FDA Link
12/2023
1RNA (Ribonucleic Acid)IBA
01/2018
1CreatinineIBA
06/2015
1TabletsIBA
03/2014
1Ritonavir (Norvir)FDA Link
04/2013
1Atazanavir Sulfate (Reyataz)FDA Link
04/2013